Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trial

AIMS: To assess the effects on glycaemic control of lixisenatide vs placebo as add‐on treatment to basal insulin (BI) ± metformin and effects on glycated haemoglobin (HbA1c) reduction in patients with insufficiently controlled type 2 diabetes (T2D). METHODS: Patients (n = 448) with inadequately cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenying, Min, Kyungwan, Zhou, Zhiguang, Li, Ling, Xu, XiangJin, Zhu, Dalong, Venkateshwar Rao, A., Murthy, Laxminarayanappa Sreenivasa, Zhang, Nianxian, Li, Ivy, Niemoeller, Elisabeth, Shang, Shuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813270/
https://www.ncbi.nlm.nih.gov/pubmed/28742225
http://dx.doi.org/10.1111/dom.13072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813270/
https://www.ncbi.nlm.nih.gov/pubmed/28742225
http://dx.doi.org/10.1111/dom.13072

Ejemplares similares